Burn Pain Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Cumberland Pharma, Janssen R&D, Cephalon

The Key Burn Pain Companies in the market include - Medical Developments International, Cumberland Pharmaceuticals, Janssen Research & Development, Cephalon, and others.

DelveInsight's "Burn Pain Market Insights, Epidemiology, and Market Forecast-2034 report offers an in-depth understanding of the Burn Pain, historical and forecasted epidemiology as well as the Burn Pain market trends in the United States, EU4 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

To Know in detail about the Burn Pain market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Burn Pain Market Forecast [https://www.delveinsight.com/report-store/burn-pain-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Some of the key facts of the Burn Pain Market Report:

*
The Burn Pain market size is anticipated to grow with a significant CAGR during the study period (2020-2034)

*
In August 2024, MediWound Ltd. (Nasdaq: MDWD), a global leader in enzymatic therapeutics for tissue repair, announced that the U.S. Food and Drug Administration (FDA) has approved NexoBrid Registered (anacaulase-bcdb) for eschar removal in pediatric patients from newborns to 18 years old with deep partial- and full-thickness thermal burns. This approval expands NexoBrid's authorization for all age groups in the U.S., aligning with its approvals in the European Union and Japan.

*
In 2023, the US maintained the largest market share among the 7MM, reaching USD 140 million. Projections indicate that this trend will persist, with the US expected to further strengthen its market dominance and remain the leading player by 2034.

*
In 2023, Germany and the UK in the EU4 and the UK both achieved market shares exceeding USD 20 million, with France following closely behind. In contrast, Italy had the smallest market share among these regions during the same period.

*
Opioid analgesics dominated the current treatment market for both inpatient and outpatient care, with an estimated market value of approximately USD 130 million in 2023.

*
In 2023, the US recorded over 2 million incident cases of burns, with numbers expected to rise by 2034.

*
In 2023, approximately 0.4 million treated incident burn cases requiring pain management therapies were reported in the US, with expectations for change during the study period from 2020 to 2034.

*
The gender distribution indicates a male dominance across the 7MM, with around 0.29 million male cases and 0.26 million female cases reported in the US in 2023.

*
Key Burn Pain Companies: Medical Developments International, Cumberland Pharmaceuticals, Janssen Research & Development, Cephalon, and others

*
Key Burn Pain Therapies: Methoxyflurane (PENTHROX), Caldolor, JNJ-42160443, ACTIQ, and others

*
The Burn Pain epidemiology based on etiology-specific cases analyzed that Etiology Specific Incident Cases of Burns is classified into Flame, Contact, Scald, Electrical, Chemical, and Others

*
The Burn Pain market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Burn Pain pipeline products will significantly revolutionize the Burn Pain market dynamics.

Burn Pain Overview

An organic tissue injury known as a burn is mostly brought on by heat, radiation, radioactivity, electricity, friction, or chemical contact.

Get a Free sample for the Burn Pain Market Report -

https://www.delveinsight.com/sample-request/burn-pain-market [https://www.delveinsight.com/sample-request/burn-pain-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Burn Pain Epidemiology

The epidemiology section provides insights into the historical, current, and forecasted epidemiology trends in the seven major countries (7MM) from 2020 to 2034. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides a detailed analysis of the diagnosed patient pool and future trends.

Burn Pain Epidemiology Segmentation:

The Burn Pain market report proffers epidemiological analysis for the study period 2020-2034 in the 7MM segmented into:

*
Total Prevalence of Burn Pain

*
Prevalent Cases of Burn Pain by severity

*
Gender-specific Prevalence of Burn Pain

*
Diagnosed Cases of Episodic and Chronic Burn Pain

Download the report to understand which factors are driving Burn Pain epidemiology trends @ Burn Pain Epidemiology Forecast [https://www.delveinsight.com/sample-request/burn-pain-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Burn Pain Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Burn Pain market or expected to get launched during the study period. The analysis covers Burn Pain market uptake by drugs, patient uptake by therapies, and sales of each drug.

Moreover, the therapeutics assessment section helps understand the drugs with the most rapid uptake and the reasons behind the maximal use of the drugs. Additionally, it compares the drugs based on market share.

The report also covers the Burn Pain Pipeline Development Activities. It provides valuable insights about different therapeutic candidates in various stages and the key companies involved in developing targeted therapeutics. It also analyzes recent developments such as collaborations, acquisitions, mergers, licensing patent details, and other information for emerging therapies.

Burn Pain Therapies and Key Companies

*
Methoxyflurane (PENTHROX): Medical Developments International

*
Caldolor: Cumberland Pharmaceuticals

*
JNJ-42160443: Janssen Research & Development

*
ACTIQ: Cephalon

Discover more about therapies set to grab major Burn Pain market share @ Burn Pain Treatment Market [https://www.delveinsight.com/sample-request/burn-pain-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Burn Pain Market Strengths

*
The increasing incidence of patients with burns is expected to propel the treatment market in the future, adding opportunities for new pharma players

Burn Pain Market Opportunities

*
The rising incidence of burn pain indicates increasing pharmacological treatment demands, thereby crafting lucrative opportunities for new pharma players

Scope of the Burn Pain Market Report

*
Study Period: 2020-2034

*
Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]

*
Key Burn Pain Companies: Medical Developments International, Cumberland Pharmaceuticals, Janssen Research & Development, Cephalon, and others

*
Key Burn Pain Therapies: Methoxyflurane (PENTHROX), Caldolor, JNJ-42160443, ACTIQ, and others

*
Burn Pain Therapeutic Assessment: Burn Pain current marketed and Burn Pain emerging therapies

*
Burn Pain Market Dynamics: Burn Pain market drivers and Burn Pain market barriers

*
Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter's five forces, BCG Matrix, Market entry strategies

*
Burn Pain Unmet Needs, KOL's views, Analyst's views, Burn Pain Market Access and Reimbursement

To know more about Burn Pain companies working in the treatment market, visit @ Burn Pain Clinical Trials and Therapeutic Assessment [https://www.delveinsight.com/sample-request/burn-pain-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=gpr]

Table of Contents

1. Burn Pain Market Report Introduction

2. Executive Summary for Burn Pain

3. SWOT analysis of Burn Pain

4. Burn Pain Patient Share (%) Overview at a Glance

5. Burn Pain Market Overview at a Glance

6. Burn Pain Disease Background and Overview

7. Burn Pain Epidemiology and Patient Population

8. Country-Specific Patient Population of Burn Pain

9. Burn Pain Current Treatment and Medical Practices

10. Burn Pain Unmet Needs

11. Burn Pain Emerging Therapies

12. Burn Pain Market Outlook

13. Country-Wise Burn Pain Market Analysis (2020-2034)

14. Burn Pain Market Access and Reimbursement of Therapies

15. Burn Pain Market Drivers

16. Burn Pain Market Barriers

17. Burn Pain Appendix

18. Burn Pain Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

About DelveInsight

DelveInsight is a leading Healthcare Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.

It also offers Healthcare Consulting Services, which benefits in market analysis to accelerate the business growth and overcome challenges with a practical approach.

Media Contact
Company Name: DelveInsight
Contact Person: Gaurav Bora
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=burn-pain-market-to-reach-new-heights-in-growth-by-2034-delveinsight-predicts-cumberland-pharma-janssen-rd-cephalon]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.